We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Takeda Court Victory Also Has Upside for Andrx
Takeda Court Victory Also Has Upside for Andrx
March 7, 2006
Takeda Pharmaceuticals’ recent court victory against Alphapharm and Mylan Pharmaceuticals over Takeda’s diabetes drug Actos could benefit Andrx, which has a deal with Takeda to develop and market a combination diabetes drug that includes Actos.